In conclusion, this study showed that patients diagnosed with NB, with MYCN amplification in combination with 11qLOH, might be less likely to respond to neoadjuvant chemotherapy when compared with patients with MYCN amplification alone. Here, MYCN is linked to neuroblastoma.